126 related articles for article (PubMed ID: 21190617)
21. [Expression and significance of telomerase reverse transcriptase and its regulators in non-small cell lung carcinoma].
Chen TX; Xiong YY; Liu L
Ai Zheng; 2004 Mar; 23(3):273-7. PubMed ID: 15025956
[TBL] [Abstract][Full Text] [Related]
22. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival.
Farhadieh RD; Smee R; Ow K; Yang JL; Russell PJ; Crouch R; Jackson P; Jacobson IV
Cancer Lett; 2004 Sep; 213(1):91-8. PubMed ID: 15312688
[TBL] [Abstract][Full Text] [Related]
24. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression.
Jackson P; Ow K; Yardley G; Delprado W; Quinn DI; Yang JL; Russell PJ
Prostate Cancer Prostatic Dis; 2003; 6(2):174-81. PubMed ID: 12806379
[TBL] [Abstract][Full Text] [Related]
26. [Expression of survivin gene and its significance in the carcinogenesis and development of non-small cell lung cancer].
Tao L; Yao F; Li H; Yu F; Wang M; Liu M
Zhongguo Fei Ai Za Zhi; 2003 Aug; 6(4):275-7. PubMed ID: 21272481
[TBL] [Abstract][Full Text] [Related]
27. Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in bladder cancer cell lines: relationship to KAI1/CD82 levels and invasive behaviour.
Rowe A; Jackson P
Oncol Rep; 2006 Dec; 16(6):1267-72. PubMed ID: 17089048
[TBL] [Abstract][Full Text] [Related]
28. [The expression of O6-methylguanine DNA methyltransferase and p53 in non-small cell lung cancer and the association with the prognosis].
Liu Y; Wang J; Zhang H; Fu XM; Wang HQ
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):427-31. PubMed ID: 20979814
[TBL] [Abstract][Full Text] [Related]
29. Loss of KAI1/CD82 expression in bone and soft tissue tumors is not associated with lung metastasis.
Arihiro K; Inai K
Pathol Res Pract; 2001; 197(9):627-33. PubMed ID: 11569927
[TBL] [Abstract][Full Text] [Related]
30. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
Jee BK; Park KM; Surendran S; Lee WK; Han CW; Kim YS; Lim Y
Biochem Biophys Res Commun; 2006 Apr; 342(2):655-61. PubMed ID: 16488391
[TBL] [Abstract][Full Text] [Related]
31. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
32. [Detection of interleukin-8 on tissue array of non-small cell lung cancer and its clinicopathological significance].
Xu C; Bian X; Wang Q; Zhang R; Chen C; Ye Q
Zhongguo Fei Ai Za Zhi; 2007 Oct; 10(5):386-90. PubMed ID: 21126406
[TBL] [Abstract][Full Text] [Related]
33. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
[TBL] [Abstract][Full Text] [Related]
35. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
[TBL] [Abstract][Full Text] [Related]
36. [A study on expression of p53, p27 and bcl-2 protein in non-small cell lung cancer].
Zhi X; Xue J; Xing L; Bo A; Zhang X
Zhongguo Fei Ai Za Zhi; 2002 Feb; 5(1):51-3. PubMed ID: 21315031
[TBL] [Abstract][Full Text] [Related]
37. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
38. [A study on the relationship between the level of E-cadherin mRNA expression and pathological characteristics of non-small cell lung cancer].
Chen X; Ding X; Yang B; Bao M; Zhu J; Wang H; Xu Z
Zhongguo Fei Ai Za Zhi; 2007 Dec; 10(6):471-6. PubMed ID: 21129302
[TBL] [Abstract][Full Text] [Related]
39. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
Chang C; Wang P; Yang H; Li L; Zhang LB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
[TBL] [Abstract][Full Text] [Related]
40. [Expression of Skp2 and its correlation with c-myc in non-small cell lung cancer].
Gao H; Zhong L; Hu K
Zhongguo Fei Ai Za Zhi; 2004 Dec; 7(6):493-6. PubMed ID: 21251405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
